75
Views
14
CrossRef citations to date
0
Altmetric
Review

Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study

, , &
Pages 467-479 | Published online: 15 Sep 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

J. Delgado Alves, E. Steinhagen-Thiessen, R. Darioli, U. Hostalek & A. Vogt. (2008) Influence of the timing of low-dose aspirin on tolerability of prolonged-release nicotinic acid in patients at elevated cardiovascular risk. Current Medical Research and Opinion 24:10, pages 2815-2820.
Read now

Articles from other publishers (13)

Masoumeh Atefi, Solmaz Mirzamohammadi, Mina Darand & Mohammad Javad Tarrahi. (2022) Meta-analysis of the effects of quinoa (Chenopodium quinoa) interventions on blood lipids. Journal of Herbal Medicine 34, pages 100571.
Crossref
Pooja Acharya, Parvati Huded, Sadashivaiah Bettadahalli, Mehrdad Zarei, Vinayak Uppin, Nayana Venugopal & Ramaprasad Ravichandra Talahalli. (2020) Withaferin-A down-regulate enterohepatic circulation of bile acids: An insight from a hyperlipidemic rat model. Journal of Agriculture and Food Research 2, pages 100035.
Crossref
Joseph M. Keenan. 2019. Dyslipidemia. Dyslipidemia.
Diana Navarro-Perez, Jessica Radcliffe, Audrey Tierney & Markandeya Jois. (2017) Quinoa Seed Lowers Serum Triglycerides in Overweight and Obese Subjects: A Dose-Response Randomized Controlled Clinical Trial. Current Developments in Nutrition 1:9, pages e001321.
Crossref
Dan Ran, Hui-juan Nie, Yu-lin Gao, Song-bai Deng, Jian-lin Du, Ya-jie Liu, Xiao-dong Jing & Qiang She. (2017) A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS): Ezetimibe and rosuvastatin versus high-dose rosuvastatin. International Journal of Cardiology 235, pages 49-55.
Crossref
Bernhard HJ Juurlink, Haya J Azouz, Alaa MZ Aldalati, Basmah MH AlTinawi & Paul Ganguly. (2014) Hydroxybenzoic acid isomers and the cardiovascular system. Nutrition Journal 13:1.
Crossref
Carmilla M. M. Licht, Eco J. C. de Geus & Brenda W. J. H. Penninx. (2013) Dysregulation of the Autonomic Nervous System Predicts the Development of the Metabolic Syndrome. The Journal of Clinical Endocrinology & Metabolism 98:6, pages 2484-2493.
Crossref
Mark J. GrahamRichard G. LeeThomas A. BellIIIIIIWuxia FuAdam E. MullickVeronica J. AlexanderWalter SingletonNick VineyRichard GearyJohn SuBrenda F. BakerJennifer BurkeyStanley T. CrookeRosanne M. Crooke. (2013) Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans. Circulation Research 112:11, pages 1479-1490.
Crossref
Clara C. Blad, Kashan Ahmed, Ad.P. IJzerman & Stefan Offermanns. 2011. Pharmacology of G Protein Coupled Receptors. Pharmacology of G Protein Coupled Receptors 219 250 .
Vivian Ojogun, Sandhya M. Vyas, Hans-Joachim Lehmler & Barbara L. Knutson. (2010) Partitioning of homologous nicotinic acid ester prodrugs (nicotinates) into dipalmitoylphosphatidylcholine (DPPC) membrane bilayers. Colloids and Surfaces B: Biointerfaces 78:1, pages 75-84.
Crossref
P. P. Toth. (2009) Clinical insights from the Fenofibrate Intervention and Event Lowering in Diabetes study: a community practice perspective. International Journal of Clinical Practice 63:6, pages 903-911.
Crossref
CKM Ho, MWJ Strachan & SW Walker. (2009) Prolonged-release nicotinic acid. Practical Diabetes International 26:4, pages 162-163.
Crossref
Roopal B. Thakkar, Moti L. Kashyap, Andrew J. Lewin, Scott L. Krause, Ping Jiang & Robert J. Padley. (2012) Acetylsalicylic Acid Reduces Niacin Extended-Release-Induced Flushing in Patients with Dyslipidemia. American Journal of Cardiovascular Drugs 9:2, pages 69-79.
Crossref